483 Concord Biosciences Sep 2016

483 Concord Biosciences Sep 2016

Richard Berning FDA$119.00 - Available Now

FDA investigators audited the Concord Biosciences - Painesville, OH, United States facility and issued inspectional observations (via FDA 483) on 23 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Sep 2016
  • Location: Painesville, United States
  • FEI: 1527393
Add To Cart